Qianyuan Pharmaceuticals: Jointly acquired a 40% stake in Qianyuan Hailisheng with Zhoushan Ronghao for 154.72 million yuan

Qianyuan Pharmaceuticals Announcement: On February 24, 2026, the company’s sixth board of directors held its second meeting, authorizing the management to jointly participate in the judicial auction of 40% equity of Zhejiang Qianyuan Hailisheng Pharmaceutical Co., Ltd. (hereinafter referred to as “Qianyuan Hailisheng”) held by Hailisheng Group Co., Ltd., using its own funds in partnership with Zhoushan Ronghao Trading Co., Ltd. (hereinafter referred to as “Zhoushan Ronghao”). The company and Zhoushan Ronghao each bid for 20% of Qianyuan Hailisheng’s equity. On February 25, 2026, according to the announcement on the Taobao judicial auction platform by the Ningbo Yinzhou District People’s Court in Zhejiang Province, the company and Zhoushan Ronghao jointly won the 40% equity of Qianyuan Hailisheng at a price of 154.72 million yuan. The company’s stake in Qianyuan Hailisheng will increase to 80%.